Skip to main content

2018 | OriginalPaper | Buchkapitel

6. Neurologische Komplikationen der Kollagenosen

verfasst von : Torsten Witte, Thomas Skripuletz

Erschienen in: Autoimmunerkrankungen in der Neurologie

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Zu den Kollagenosen zählen der systemische Lupus erythematodes, das Sjögren-Syndrom, die Sklerodermie und die Poly-/Dermatomyositis. Neurologische Komplikationen sowohl des zentralen als auch des peripheren Nervensystems sind bei den Kollagenosen häufig. Sie sind daher bei vielen neurologischen Erkrankungen Differenzialdiagnosen. In dem Kapitel werden die Symptome, die Diagnostik und die Therapie des systemischen Lupus erythematodes, des Sjögren-Syndroms und der Sklerodermie sowie die jeweiligen neurologischen Komplikationen dieser Krankheitsbilder vorgestellt.
Literatur
Zurück zum Zitat Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, Buchem MA van, Vollenhoven R van, Ward M, Gordon C, Boumpas DT (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69:2074–2082 CrossRefPubMed Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, Buchem MA van, Vollenhoven R van, Ward M, Gordon C, Boumpas DT (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69:2074–2082 CrossRefPubMed
Zurück zum Zitat Daniels TE (1984) Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 27:147–156 CrossRefPubMed Daniels TE (1984) Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 27:147–156 CrossRefPubMed
Zurück zum Zitat Delalande S, Seze J de, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280–291 CrossRef Delalande S, Seze J de, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280–291 CrossRef
Zurück zum Zitat Farrell DA, Medsger TA Jr (1982) Trigeminal neuropathy in progressive systemic sclerosis. Am J Med 73:57–62 CrossRefPubMed Farrell DA, Medsger TA Jr (1982) Trigeminal neuropathy in progressive systemic sclerosis. Am J Med 73:57–62 CrossRefPubMed
Zurück zum Zitat Gøransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellgren SI, Omdal R (2006) Peripheral neuropathy in primary sjogren syndrome: a population-based study. Arch Neurol 63:1612–1615 CrossRefPubMed Gøransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellgren SI, Omdal R (2006) Peripheral neuropathy in primary sjogren syndrome: a population-based study. Arch Neurol 63:1612–1615 CrossRefPubMed
Zurück zum Zitat Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, Ginzler E, Aranow C, Wallace DJ, Ramsey-Goldman R, Vollenhoven R van, Sturfelt G, Nived O, Sanchez-Guerrero J, Alarcón GS, Petri M, Khamashta M, Zoma A, Font J, Kalunian K, Douglas J, Qi Q, Thompson K, Merrill JT (Systemic Lupus International Collaborating Clinics) (2008) Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 58:843–853 Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, Ginzler E, Aranow C, Wallace DJ, Ramsey-Goldman R, Vollenhoven R van, Sturfelt G, Nived O, Sanchez-Guerrero J, Alarcón GS, Petri M, Khamashta M, Zoma A, Font J, Kalunian K, Douglas J, Qi Q, Thompson K, Merrill JT (Systemic Lupus International Collaborating Clinics) (2008) Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 58:843–853
Zurück zum Zitat Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, Clarke A, Bernatsky S, Isenberg D, Rahman A, Alarcón GS, Gladman DD, Fortin PR, Sanchez-Guerrero J, Romero-Diaz J, Merrill JT, Ginzler E, Bruce IN, Steinsson K, Khamashta M, Petri M, Manzi S, Dooley MA, Ramsey-Goldman R, Vollenhoven R van, Nived O, Sturfelt G, Aranow C, Kalunian K, Ramos-Casals M, Zoma A, Douglas J, Thompson K, Farewell V (Systemic Lupus International Collaborating Clinics) (2010) Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 69:529–535 Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, Clarke A, Bernatsky S, Isenberg D, Rahman A, Alarcón GS, Gladman DD, Fortin PR, Sanchez-Guerrero J, Romero-Diaz J, Merrill JT, Ginzler E, Bruce IN, Steinsson K, Khamashta M, Petri M, Manzi S, Dooley MA, Ramsey-Goldman R, Vollenhoven R van, Nived O, Sturfelt G, Aranow C, Kalunian K, Ramos-Casals M, Zoma A, Douglas J, Thompson K, Farewell V (Systemic Lupus International Collaborating Clinics) (2010) Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 69:529–535
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725 CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725 CrossRefPubMed
Zurück zum Zitat Jara LJ, Pacheco-Reyes H, Medina G, Angeles U, Cruz-Cruz P, Saavedra MA (2007) Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy. Ann N Y Acad Sci 1108:218–226 CrossRefPubMed Jara LJ, Pacheco-Reyes H, Medina G, Angeles U, Cruz-Cruz P, Saavedra MA (2007) Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy. Ann N Y Acad Sci 1108:218–226 CrossRefPubMed
Zurück zum Zitat Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P (2004) Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 46:15–21 CrossRefPubMed Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P (2004) Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 46:15–21 CrossRefPubMed
Zurück zum Zitat Joven BE, Almodovar R, Carmona L, Carreira PE (2010) Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum 39:285–293 CrossRefPubMed Joven BE, Almodovar R, Carmona L, Carreira PE (2010) Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum 39:285–293 CrossRefPubMed
Zurück zum Zitat Kaul M, Erkan D, Sammaritano L, Lockshin MD (2007) Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis 66:927–930 CrossRefPubMedPubMedCentral Kaul M, Erkan D, Sammaritano L, Lockshin MD (2007) Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis 66:927–930 CrossRefPubMedPubMedCentral
Zurück zum Zitat Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, Hoogen F van den, Wigley F, Zulian F, Matucci-Cerinic M (EUSTAR Co-Authors) (2009). EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) Ann Rheum Dis 68:620–628 Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, Hoogen F van den, Wigley F, Zulian F, Matucci-Cerinic M (EUSTAR Co-Authors) (2009). EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) Ann Rheum Dis 68:620–628
Zurück zum Zitat Lee P, Bruni J, Sukenik S (1984) Neurological manifestations in systemic sclerosis (scleroderma). J Rheumatol 11:480–483 PubMed Lee P, Bruni J, Sukenik S (1984) Neurological manifestations in systemic sclerosis (scleroderma). J Rheumatol 11:480–483 PubMed
Zurück zum Zitat Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR (2002) Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065–1070 CrossRefPubMedPubMedCentral Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR (2002) Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065–1070 CrossRefPubMedPubMedCentral
Zurück zum Zitat Masi G, Annunziata P (2016) Sjogren’s syndrome and multiple sclerosis: two sides of the same coin? Autoimmun Rev 15:457–461 CrossRefPubMed Masi G, Annunziata P (2016) Sjogren’s syndrome and multiple sclerosis: two sides of the same coin? Autoimmun Rev 15:457–461 CrossRefPubMed
Zurück zum Zitat McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11:85–89 CrossRefPubMed McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11:85–89 CrossRefPubMed
Zurück zum Zitat Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H (2010) Effectiveness of rituximab treatment in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62:960–968 CrossRefPubMed Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H (2010) Effectiveness of rituximab treatment in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62:960–968 CrossRefPubMed
Zurück zum Zitat Mitsikostas DD, Sfikakis PP, Goadsby PJ (2004) A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 127:1200–1209 CrossRefPubMed Mitsikostas DD, Sfikakis PP, Goadsby PJ (2004) A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 127:1200–1209 CrossRefPubMed
Zurück zum Zitat Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H et al (2005) The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy. Brain 128:2518–2534 CrossRefPubMed Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H et al (2005) The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy. Brain 128:2518–2534 CrossRefPubMed
Zurück zum Zitat Moser KL, Kelly JA, Lessard CJ, Harley JB (2009) Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10:373–379 CrossRefPubMedPubMedCentral Moser KL, Kelly JA, Lessard CJ, Harley JB (2009) Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10:373–379 CrossRefPubMedPubMedCentral
Zurück zum Zitat Muñoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M (2010) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6:280–289 CrossRefPubMed Muñoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M (2010) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6:280–289 CrossRefPubMed
Zurück zum Zitat Pars K, Pul R, Schwenkenbecher P, Sühs KW, Wurster U, Witte T, Bronzlik P, Stangel M, Skripuletz T (2017) Cerebrospinal fluid findings in neurological diseases associated with Sjögren’s syndrome. Eur Neurol 77:91–102 CrossRefPubMed Pars K, Pul R, Schwenkenbecher P, Sühs KW, Wurster U, Witte T, Bronzlik P, Stangel M, Skripuletz T (2017) Cerebrospinal fluid findings in neurological diseases associated with Sjögren’s syndrome. Eur Neurol 77:91–102 CrossRefPubMed
Zurück zum Zitat Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590 CrossRef Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590 CrossRef
Zurück zum Zitat Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, Coenen MJ, Vonk MC, Voskuyl AE, Schuerwegh AJ, Broen JC, Riel PL van, van ’t Slot R, Italiaander A, Ophoff RA, Riemekasten G, Hunzelmann N, Simeon CP, Ortego-Centeno N, González-Gay MA, González-Escribano MF; Spanish Scleroderma Group, Airo P, Laar J van, Herrick A, Worthington J, Hesselstrand R, Smith V, Keyser F de, Houssiau F, Chee MM, Madhok R, Shiels P, Westhovens R, Kreuter A, Kiener H, Baere E de, Witte T, Padykov L, Klareskog L, Beretta L, Scorza R, Lie BA, Hoffmann-Vold AM, Carreira P, Varga J, Hinchcliff M, Gregersen PK, Lee AT, Ying J, Han Y, Weng SF, Amos CI, Wigley FM, Hummers L, Nelson JL, Agarwal SK, Assassi S, Gourh P, Tan FK, Koeleman BP, Arnett FC, Martin J, Mayes MD (2010) Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 42:426–429 CrossRefPubMedPubMedCentral Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, Coenen MJ, Vonk MC, Voskuyl AE, Schuerwegh AJ, Broen JC, Riel PL van, van ’t Slot R, Italiaander A, Ophoff RA, Riemekasten G, Hunzelmann N, Simeon CP, Ortego-Centeno N, González-Gay MA, González-Escribano MF; Spanish Scleroderma Group, Airo P, Laar J van, Herrick A, Worthington J, Hesselstrand R, Smith V, Keyser F de, Houssiau F, Chee MM, Madhok R, Shiels P, Westhovens R, Kreuter A, Kiener H, Baere E de, Witte T, Padykov L, Klareskog L, Beretta L, Scorza R, Lie BA, Hoffmann-Vold AM, Carreira P, Varga J, Hinchcliff M, Gregersen PK, Lee AT, Ying J, Han Y, Weng SF, Amos CI, Wigley FM, Hummers L, Nelson JL, Agarwal SK, Assassi S, Gourh P, Tan FK, Koeleman BP, Arnett FC, Martin J, Mayes MD (2010) Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 42:426–429 CrossRefPubMedPubMedCentral
Zurück zum Zitat Rihl M, Ulbricht K, Schmidt RE, Witte T (2009) Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren’s syndrome. Rheumatology 48:796–799 CrossRefPubMed Rihl M, Ulbricht K, Schmidt RE, Witte T (2009) Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren’s syndrome. Rheumatology 48:796–799 CrossRefPubMed
Zurück zum Zitat Schady W, Sheard A, Hassell A, Holt L, Jayson MI, Klimiuk P (1991) Peripheral nerve dysfunction in scleroderma. Q J Med 80:661–675 PubMed Schady W, Sheard A, Hassell A, Holt L, Jayson MI, Klimiuk P (1991) Peripheral nerve dysfunction in scleroderma. Q J Med 80:661–675 PubMed
Zurück zum Zitat Seze J de, Devos D, Castelnovo G, Labauge P, Dubucquoi S, Stojkovic T, Ferriby D, Vermersch P (2001) The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology 57:1359–1363 CrossRefPubMed Seze J de, Devos D, Castelnovo G, Labauge P, Dubucquoi S, Stojkovic T, Ferriby D, Vermersch P (2001) The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology 57:1359–1363 CrossRefPubMed
Zurück zum Zitat Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’ Syndrome Criteria Working Group 2016 (2017) American College of Rheumatology/European League Against Rheumatism Classification criteria for Primary Sjögren’s syndrome. Arthritis Rheum 69:35–45 Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’ Syndrome Criteria Working Group 2016 (2017) American College of Rheumatology/European League Against Rheumatism Classification criteria for Primary Sjögren’s syndrome. Arthritis Rheum 69:35–45
Zurück zum Zitat Smith V, Vanthuyne M, Vander Cruyssen B, Van Praet J, Vermeiren F, Smets H, Houssiau F, De Keyser F (2008) Over-representation of construction-related occupations in male patients with systemic sclerosis. Ann Rheum Dis 67:1448–1450 CrossRefPubMed Smith V, Vanthuyne M, Vander Cruyssen B, Van Praet J, Vermeiren F, Smets H, Houssiau F, De Keyser F (2008) Over-representation of construction-related occupations in male patients with systemic sclerosis. Ann Rheum Dis 67:1448–1450 CrossRefPubMed
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277 CrossRefPubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277 CrossRefPubMed
Zurück zum Zitat The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599–608 The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599–608
Zurück zum Zitat Tokunaga M, Saito K, Kawabata D, Imura Y, Fujii T, Nakayamada S, Tsujimura S, Nawata M, Iwata S, Azuma T, Mimori T, Tanaka Y (2007) Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis 66:470–475 CrossRefPubMed Tokunaga M, Saito K, Kawabata D, Imura Y, Fujii T, Nakayamada S, Tsujimura S, Nawata M, Iwata S, Azuma T, Mimori T, Tanaka Y (2007) Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis 66:470–475 CrossRefPubMed
Zurück zum Zitat Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, Lefebvre PGP de la, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815 CrossRefPubMed Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, Lefebvre PGP de la, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815 CrossRefPubMed
Zurück zum Zitat Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O’Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 42:46–50 CrossRef Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O’Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 42:46–50 CrossRef
Zurück zum Zitat Versura P, Frigato M, Cellini M, Mulè R, Malavolta N, Campos EC (2007) Diagnostic performance of tear function tests in Sjogren’s syndrome patients. Eye 21:229–237 CrossRefPubMed Versura P, Frigato M, Cellini M, Mulè R, Malavolta N, Campos EC (2007) Diagnostic performance of tear function tests in Sjogren’s syndrome patients. Eye 21:229–237 CrossRefPubMed
Zurück zum Zitat Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren’s syndrome. Arthritis Rheum 62:1198–1200 CrossRefPubMed Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren’s syndrome. Arthritis Rheum 62:1198–1200 CrossRefPubMed
Zurück zum Zitat Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, Otto P, Nitzsche EU, Moser E, Peter HH (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59:377–385 CrossRefPubMedPubMedCentral Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, Otto P, Nitzsche EU, Moser E, Peter HH (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59:377–385 CrossRefPubMedPubMedCentral
Zurück zum Zitat Wernicke D, Hess H, Gromnica-Ihle E, Krause A, Schmidt WA (2008) Ultrasonography of salivary glands – a highly specific imaging procedure for diagnosis of Sjögren’s syndrome. J Rheumatol 35:285–293 PubMed Wernicke D, Hess H, Gromnica-Ihle E, Krause A, Schmidt WA (2008) Ultrasonography of salivary glands – a highly specific imaging procedure for diagnosis of Sjögren’s syndrome. J Rheumatol 35:285–293 PubMed
Zurück zum Zitat Witte T, Bierwirth J, Schmidt RE, Matthias T (2006) Antibodies against alpha-fodrin are associated with dry eyes and mouth in the general population. J Rheumatol 33:1713 PubMed Witte T, Bierwirth J, Schmidt RE, Matthias T (2006) Antibodies against alpha-fodrin are associated with dry eyes and mouth in the general population. J Rheumatol 33:1713 PubMed
Metadaten
Titel
Neurologische Komplikationen der Kollagenosen
verfasst von
Torsten Witte
Thomas Skripuletz
Copyright-Jahr
2018
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-662-55530-9_6